Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SAMEH REFAT GABALLA

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1659534238
CMS profile
723980
Location
TAMPA, FL

General Payments · PY2018–2024

$195,601.14

  • Reported across 156 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$48,782.59

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ADC Therapeutics America, Inc. $18,135.81 10
Lilly USA, LLC $14,140.60 14
Regeneron Pharmaceuticals, Inc. $8,393.16 5
Ipsen Biopharmaceuticals, Inc $4,920.00 1
Acerta Pharma LLC $2,930.00 2
Genmab U.S., Inc. $138.02 1
Kite Pharma, Inc. $125.00 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $17,546.43 23
PY2019 $40,563.29 29
PY2020 $4,900.00 2
PY2021 $22,681.98 13
PY2022 $29,889.36 17
PY2023 $31,237.49 38
PY2024 $48,782.59 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ADC Therapeutics America, Inc. $730.00 02/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1121193209 CMS
ADC Therapeutics America, Inc. $2,920.00 03/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1121193219 CMS
ADC Therapeutics America, Inc. $688.20 05/01/2024 Travel and Lodging Undisputed 01/23/2026 1121193235 CMS
ADC Therapeutics America, Inc. $108.88 05/17/2024 Food and Beverage Undisputed 01/23/2026 1121193237 CMS
ADC Therapeutics America, Inc. $237.48 05/18/2024 Travel and Lodging Undisputed 01/23/2026 1121193239 CMS
ADC Therapeutics America, Inc. $7,300.00 05/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1121193241 CMS
ADC Therapeutics America, Inc. $124.01 05/24/2024 Food and Beverage Undisputed 01/23/2026 1121193247 CMS
ADC Therapeutics America, Inc. $5,840.00 05/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1121193249 CMS
ADC Therapeutics America, Inc. $11.61 06/05/2024 Food and Beverage Undisputed 01/23/2026 1121193251 CMS
ADC Therapeutics America, Inc. $175.63 06/05/2024 Travel and Lodging Undisputed 01/23/2026 1121193253 CMS
AstraZeneca Pharmaceuticals LP $60.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 1105594567 CMS
AstraZeneca Pharmaceuticals LP $2,870.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 1104537584 CMS
Genmab U.S., Inc. $138.02 08/20/2024 Food and Beverage Undisputed 01/23/2026 1126831762 CMS
Ipsen Biopharmaceuticals, Inc $4,920.00 08/30/2024 Consulting Fee Undisputed 01/23/2026 1091952906 CMS
Kite Pharma, Inc. $125.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 1128610217 CMS
Lilly USA, LLC $1,406.25 02/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135342095 CMS
Lilly USA, LLC $440.30 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1135342087 CMS
Lilly USA, LLC $530.34 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1135342091 CMS
Lilly USA, LLC $189.84 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1135372374 CMS
Lilly USA, LLC $139.12 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1135388651 CMS
Lilly USA, LLC $144.12 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1135411435 CMS
Lilly USA, LLC $497.74 03/02/2024 Travel and Lodging Undisputed 01/23/2026 1135412927 CMS
Lilly USA, LLC $2,500.00 03/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135362810 CMS
Lilly USA, LLC $2,200.00 03/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135412929 CMS
Lilly USA, LLC $1,250.00 03/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135384535 CMS
Lilly USA, LLC $672.64 05/14/2024 Travel and Lodging Undisputed 01/23/2026 1135384533 CMS
Lilly USA, LLC $95.25 05/14/2024 Food and Beverage Undisputed 01/23/2026 1135388653 CMS
Lilly USA, LLC $1,575.00 05/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135402301 CMS
Lilly USA, LLC $2,500.00 05/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1135411437 CMS
Regeneron Pharmaceuticals, Inc. $3,528.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1114398939 CMS
Regeneron Pharmaceuticals, Inc. $4,704.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1114398941 CMS
Regeneron Pharmaceuticals, Inc. $55.07 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1114398943 CMS
Regeneron Pharmaceuticals, Inc. $43.75 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1114398945 CMS
Regeneron Pharmaceuticals, Inc. $62.34 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1114398947 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.